Chuanning Biology (301301.SZ): The net income in the first half of the year was 0.766 billion yuan, an increase of 96.05% year-on-year.

Gelonghui Finance · Aug 26 05:58

Gelonghui, August 26th, Chuan Ning Bioscience (301301.SZ) released its semi-annual report for 2024, with a reported half-year revenue of 3.195 billion yuan, a year-on-year increase of 32.20%; net income attributable to shareholders of the listed company was 0.766 billion yuan, a year-on-year increase of 96.05%; net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 0.766 billion yuan, a year-on-year increase of 95.02%; basic earnings per share was 0.34 yuan.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more

川宁生物(301301.SZ)：上半年净利润7.66亿元 同比增长96.05%

Chuanning Biology (301301.SZ): The net income in the first half of the year was 0.766 billion yuan, an increase of 96.05% year-on-year.

Risk Disclaimer

Statement

川宁生物(301301.SZ)：上半年净利润7.66亿元同比增长96.05%